NeoGenomics, Inc.NEONASDAQ
LOADING
|||
R&D Expense Growth Recovery in Progress
Trending higher, below historical average, structural decline.
Left:
||||
Year-over-year research & development expense growth
Latest
14.10%
↓ 66% below average
Average (9y)
41.60%
Historical baseline
Range
High:182.81%
Low:-21.79%
CAGR
-14.2%
Structural decline
| Period | Value |
|---|---|
| 2024 | 14.10% |
| 2023 | -9.95% |
| 2022 | 38.65% |
| 2021 | 165.80% |
| 2020 | -3.04% |
| 2019 | 182.81% |
| 2018 | -17.46% |
| 2017 | -21.79% |
| 2016 | 10.74% |
| 2015 | 56.12% |